// App-Quantinova.ai

P308 2016 EPI : Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease

Researchers

Presenter

  • Ken Williams

Principal Investigators

  • KenAnCo Biostatistics

  • Kathleen K Altobelli

  • Michael J Pencina

  • Christopher P Cannon

  • Allan D Sniderman

Medical Centers

  • Duke Clinical Research Institute, Durham, NC

  • KenAnCo Biostatistics, San Antonio, TX

  • Harvard Clinical Rsch Institure, Boston, MA

  • McGill, Montreal, QC, Canada

  • San Antonio, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved